Home

novn

Value Investing Congress Blog ยป Good Things Come to Those with Patience

By Nick on Wed, 2008-02-13 23:26
(via blog.valueinvestingcongress.com)

Excerpt: "Noven Pharmaceuticals (Nasdaq: NOVN) recently made significant changes to its board of directors and senior management. The company hired a new CFO, accepted the resignation of its long time Chairman and CEO Robert C. Strauss, and appointed Wayne P. Yetter as its new Chairman. We applaud these actions and believe a tremendous amount of value will come from the changes."

West Coast Asset Mgmt Present Its 50% Upside Idea--Noven Pharmaceuticals (NOVN)

By SilverSlime on Fri, 2007-11-30 05:20
(via www.streetinsider.com)

West Coast believes Noven Pharmaceuticals should move 50% higher. Noven has a low enterprise value and looks ripe for an investment. (Reporting From Value Investing Congress)